SK282945B6 - Perorálny prípravok na prevenciu a liečbu infekčných gastroenteritíd prasiat - Google Patents

Perorálny prípravok na prevenciu a liečbu infekčných gastroenteritíd prasiat Download PDF

Info

Publication number
SK282945B6
SK282945B6 SK237-99A SK23799A SK282945B6 SK 282945 B6 SK282945 B6 SK 282945B6 SK 23799 A SK23799 A SK 23799A SK 282945 B6 SK282945 B6 SK 282945B6
Authority
SK
Slovakia
Prior art keywords
capm
strains
porcine
antibodies
bacteria
Prior art date
Application number
SK237-99A
Other languages
English (en)
Slovak (sk)
Other versions
SK23799A3 (en
Inventor
Petr Mi�An
Jan �T�P�Nek
Original Assignee
Medipharm Cz, S. R. O.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medipharm Cz, S. R. O. filed Critical Medipharm Cz, S. R. O.
Publication of SK23799A3 publication Critical patent/SK23799A3/sk
Publication of SK282945B6 publication Critical patent/SK282945B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/02—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/40—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum bacterial
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SK237-99A 1998-03-20 1999-02-24 Perorálny prípravok na prevenciu a liečbu infekčných gastroenteritíd prasiat SK282945B6 (sk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CZ1998859A CZ287989B6 (cs) 1998-03-20 1998-03-20 Perorální přípravek k prevenci a léčbě infekčních gastroenteritid prasat

Publications (2)

Publication Number Publication Date
SK23799A3 SK23799A3 (en) 1999-10-08
SK282945B6 true SK282945B6 (sk) 2003-01-09

Family

ID=5462362

Family Applications (1)

Application Number Title Priority Date Filing Date
SK237-99A SK282945B6 (sk) 1998-03-20 1999-02-24 Perorálny prípravok na prevenciu a liečbu infekčných gastroenteritíd prasiat

Country Status (4)

Country Link
EP (1) EP0955061A1 (cs)
CZ (1) CZ287989B6 (cs)
PL (1) PL191391B1 (cs)
SK (1) SK282945B6 (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100437497B1 (ko) * 2001-03-07 2004-06-25 주식회사 프로바이오닉 로타바이러스 및 유해 미생물 억제 활성을 가지는 신규내산성 락토바실러스 루테리 프로바이오-16 및 이를함유하는 생균활성제
KR100542483B1 (ko) * 2001-11-30 2006-01-16 주식회사 에그 바이오택 유아설사의 발병원인체인 대장균, 로타바이러스,아스트로바이러스에 대한 복합특수면역단백질을 함유한계란생산방법과 상기 계란에서 분리한복합특수면역단백질을 함유한 난황분말, 조제분유
KR100471116B1 (ko) * 2001-12-12 2005-03-08 주식회사 단바이오텍 장독성 대장균 감염의 예방 및 치료에 유용한 수용성단백질 및 이를 포함한 알 및 이들의 제조 방법
WO2003061693A1 (en) * 2001-12-28 2003-07-31 Camas, Incorporated Immunogen adherence and method of making and using same
KR100585392B1 (ko) * 2002-01-24 2006-05-30 주식회사 프로바이오닉 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 살리바리우스 Probio-37 및 이를 함유하는 생균활성제
KR100585391B1 (ko) * 2002-01-24 2006-06-01 주식회사 프로바이오닉 돼지 전염성위장염 (TGE) 코로나바이러스 및 유해 미생물 억제 활성을 갖는 신규 락토바실러스 프란타럼 Probio-38 및 이를 함유하는 생균활성제
KR100492492B1 (ko) * 2002-03-07 2005-05-31 주식회사 에그 바이오택 대장균(k88), 대장균(k99), 유행성설사병바이러스, 전염성위장염바이러스에 대한 복합특수면역단백질을 함유한 계란을 생산하는 방법 및 상기 방법으로 생산한 계란
CA2404356A1 (en) * 2002-09-18 2004-03-18 Canadian Inovatech Inc. Gram-positive antibacterial composition and method for use
WO2005005481A2 (en) * 2003-07-10 2005-01-20 Avitek Pharma Inc. Combination therapy for gastroenteric diseases caused by microorganisms
AU2003247193A1 (en) * 2003-07-23 2005-02-04 M.D.Lab Corp. Acid tolerant probiotic lactobacillus plantarum probio-38 that can suppress the growth of pathogenic microorganism and tge coronavirus
JP2007502292A (ja) * 2003-08-14 2007-02-08 メリアル リミテッド クリプトスポリジウム・パルブムの抗原と他の病原体の抗原とを含む組成物及びワクチン
US20100183768A1 (en) * 2007-06-28 2010-07-22 Karsten Baaner Treatment of cell suspension
US20120177650A1 (en) * 2009-09-23 2012-07-12 Borody Thomas J Therapy for enteric infections
GB2484126A (en) 2010-09-30 2012-04-04 Univ Plymouth Foodstuff fermented with lactic acid producing bacteria
DE102011006781A1 (de) * 2011-04-05 2012-10-11 Mat-Malta Advanced Technologies Limited Antikörperprodukt, umfassend n spezifische Antikörper
DE102011006809A1 (de) 2011-04-05 2012-10-11 Freistaat Bayern vertreten durch die Julius-Maximilians-Universität Würzburg Verwendung eines Mittels aus Antikörpern und/oder Insulin-like growth factor-Antagonisten
KR101353084B1 (ko) * 2011-12-30 2014-01-17 대한민국 가금분변에서 분리한 항생제저항성 포도상구균과 살모넬라를 억제하는 신규유산균 락토바실러스 살리바리우스
AR115757A1 (es) * 2018-07-13 2021-02-24 Cj Cheiljedang Corp Composición que comprende la cepa cjlp475 de lactobacillus plantarum y la cepa cjlp17 de lactobacillus plantarum y el uso de la misma

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994021284A1 (en) * 1993-03-15 1994-09-29 Pharma Pacific Pty. Ltd. Therapeutic formulation and method
JPH10298105A (ja) * 1997-04-23 1998-11-10 Gen Corp:Kk 腸管出血性大腸菌による感染症の予防剤および治療剤
CZ287956B6 (cs) * 1997-11-04 2001-03-14 Medipharm Cz, S. R. O. Perorální přípravek k prevenci a léčbě parvovirózy psů

Also Published As

Publication number Publication date
EP0955061A1 (en) 1999-11-10
CZ85998A3 (cs) 1998-10-14
PL191391B1 (pl) 2006-05-31
PL332146A1 (en) 1999-09-27
CZ287989B6 (cs) 2001-03-14
SK23799A3 (en) 1999-10-08

Similar Documents

Publication Publication Date Title
SK282945B6 (sk) Perorálny prípravok na prevenciu a liečbu infekčných gastroenteritíd prasiat
Gharib et al. Comparison of the effects of probiotic, organic acid and medicinal plant on Campylobacter jejuni challenged broiler chickens
JP4073922B2 (ja) ビフィズス菌増殖促進成分を含有する飼料組成物とその使用方法
Quigley Iii et al. Effects of oral antibiotics or bovine plasma on survival, health and growth in dairy calves challenged with Escherichia coli
BR112020022085A2 (pt) lactobacillus plantarum cjlp17 que apresenta eficácias antiviral e imunomodulatória e composição que compreende o mesmo
CN112996808A (zh) 用于治疗动物急性腹泻和肠道感染的组合物和方法
Murayama et al. Effects of orally administered Clostridium butyricum MIYAIRI 588 on mucosal immunity in mice
CN108371247A (zh) 一种提高仔猪存活率的复合益生菌
CN104721443B (zh) 一种用于防治仔猪腹泻的中药复方制剂及其制备方法
EP0930316B1 (en) Oral product for the prevention and treatment of infectious gastroenteritides in calves
CN103919816B (zh) 一种防治新生家畜腹泻的复合益生菌喷雾剂及其制备方法
SK283072B6 (sk) Perorálny prípravok na prevenciu a liečbu parvovirózy psov a spôsob jeho výroby
JP6918144B2 (ja) ラクトバチルス・プランタルムｃｊｌｐ４７５菌株とラクトバチルス・プランタルムｃｊｌｐ２４３菌株とを含む組成物及びその用途
KR100956648B1 (ko) 돼지질병의 항원 제조방법 및 면역 난황항체 생산과전해질을 첨가한 돼지질병 방제용 조성물
US20210252148A1 (en) Composition and Methods for Preventing and Treating African Swine Fever in Wild and Domestic Swine
JPH119196A (ja) キトサンによる家畜の損耗防止の方法
CN108378237A (zh) 仔猪配方奶其制备方法
CN1178703A (zh) 幼儿胃肠安制剂及其生产工艺
RU2471359C1 (ru) Способ коррекции иммунобиологических показателей у поросят в период отъема
KR100492492B1 (ko) 대장균(k88), 대장균(k99), 유행성설사병바이러스, 전염성위장염바이러스에 대한 복합특수면역단백질을 함유한 계란을 생산하는 방법 및 상기 방법으로 생산한 계란
US6296879B1 (en) Ruminal fluid inoculation of calves
JP2021193979A (ja) 家畜の初乳品質改善剤及び方法
BG3644U1 (bg) Биологично-активен полибактериален продукт за имуностимулация при животни
KR20030012563A (ko) 항생제 대체를 위한 사료 조성물
JP2004352693A (ja) 抗パルボウイルス感染症組成物

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20160224